May 9 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2018 Mar 31, 2017 Mar 31, 2019 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 4.39 4.70 4.70 2.27
(-6.7 pct) (-12.0 pct) (+7.1 pct) (+13.1 pct)
Operating 456 mln 474 mln 400 mln 230 mln
(-3.9 pct) (+7.3 pct) (-12.4 pct) (+42.2 pct)
Recurring 477 mln 468 mln 400 mln 230 mln
(+2.0 pct) (+6.2 pct) (-16.2 pct) (+27.7 pct)
Net 277 mln 309 mln 280 mln 155 mln
(-10.3 pct) (+4.5 pct) (+0.7 pct) (+22.0 pct)
EPS 66.49 yen 74.12 yen 66.98 yen 37.08 yen
Ann Div 12.50 yen 12.50 yen 12.50 yen
-Q2 Div NIL NIL NIL
-Q4 Div 12.50 yen 12.50 yen 12.50 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T